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Diagnostic Performance of Stress
Cardiac Magnetic Resonance Imaging
in the Detection of Coronary Artery Disease
A Meta-Analysis
Kiran R. Nandalur, MD,* Ben A. Dwamena, MD,*† Asim F. Choudhri, MD,‡
Mohan R. Nandalur, MD,§ Ruth C. Carlos, MD, MS*
Ann Arbor, Michigan; Charlottesville, Virginia; and Washington, DC
Objectives The purpose of our study was to conduct an evidence-based evaluation of stress cardiac magnetic resonance
imaging (MRI) in the diagnosis of coronary artery disease (CAD).
Background Stress cardiac MRI has recently emerged as a noninvasive method in the detection of CAD, with 2 main tech-
niques in use: 1) perfusion imaging; and 2) stress-induced wall motion abnormalities imaging.
Methods We examined studies from January 1990 to January 2007 using MEDLINE and EMBASE. A study was included if
it: 1) used stress MRI as a diagnostic test for CAD (50% diameter stenosis); and 2) used catheter X-ray angiog-
raphy as the reference standard.
Results Thirty-seven studies (2,191 patients) met the inclusion criteria, with 14 datasets (754 patients) using stress-
induced wall motion abnormalities imaging and 24 datasets (1,516 patients) using perfusion imaging. Stress-
induced wall motion abnormalities imaging demonstrated a sensitivity of 0.83 (95% confidence interval [CI]
0.79 to 0.88) and specificity of 0.86 (95% CI 0.81 to 0.91) on a patient level (disease prevalence  70.5%). Per-
fusion imaging demonstrated a sensitivity of 0.91 (95% CI 0.88 to 0.94) and specificity of 0.81 (95% CI 0.77 to
0.85) on a patient level (disease prevalence  57.4%).
Conclusions In studies with high disease prevalence, stress cardiac MRI, using either technique, demonstrates overall good
sensitivity and specificity for the diagnosis of CAD. However, limited data are available regarding use of either
technique in populations with low disease prevalence. (J Am Coll Cardiol 2007;50:1343–53) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.030a
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coninvasive imaging for the evaluation of coronary artery
isease (CAD) is currently largely performed by: 1) ana-
omical imaging, such as coronary multidetector computed
omography or coronary magnetic resonance angiography,
hich directly visualize the arteries; or 2) functional imag-
ng, such as single-photon emission tomography (SPECT)
r echocardiography, which evaluate the hemodynamic
equelae of coronary obstructive disease.
While the accuracy of these respective modalities has
een assessed extensively, the diagnostic capabilities of
tress cardiac magnetic resonance imaging (MRI), which
rom the *Department of Radiology, University of Michigan Health System, Ann
rbor, Michigan; †Department of Nuclear Medicine, Veterans Affairs, Ann Arbor
ealth Care System, Ann Arbor, Michigan; ‡Department of Radiology, University of
irginia Health System, Charlottesville, Virginia; and the §Department of Cardio-
ascular Medicine, Georgetown University/Washington Hospital Center, Washing-
on, DC.C
Manuscript received February 23, 2007; revised manuscript received May 9, 2007,
ccepted June 25, 2007.ppears promising given its excellent depiction of wall
otion, high contrast, spatial resolution, and lack of
onizing radiation, has only been examined by studies of
imited sample size. This has led to studies with wide
onfidence intervals (CIs) for sensitivity and specificity
nd potentially unreliable estimates of performance.
oreover, stress cardiac MRI is performed with 2 very
ifferent techniques: 1) dynamic first-pass perfusion im-
ging, which assesses for inducible perfusion defects,
ndicating impaired perfusion reserve; and 2) stress-
nduced wall motion abnormalities imaging, which eval-
ates for impairment of regional endocardial excursion
nd myocardial thickening, also indicating underlying
schemia. To overcome these issues and to provide an
vidence-based evaluation of the clinical utility of stress
RI, we performed a comprehensive meta-analysis of all
urrently published studies comparing stress MRI with
atheter-based X-ray angiography in the diagnosis of
AD.
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Data sources and searches.
We searched MEDLINE and
EMBASE for English and non-
English literature published from
January 1990 to January 2007
evaluating for the presence of
CAD in native or non-native
coronary arteries by stress MRI
and catheter-based X-ray an-
iography in the same patients. The search included medical
ubject headings for magnetic resonance, perfusion, wall
otion, and coronary angiography with the exploded term
coronary artery disease.” Moreover, we evaluated bibliog-
aphies of retrieved articles, review articles, and textbooks.
he retrieved studies were examined for potentially dupli-
ate or overlapping data. Corresponding investigators were
ontacted for clarification when data were unclear or inad-
quate. Meeting abstracts provide insufficient information
egarding their data, lack finality regarding the results, and
ere excluded.
tudy selection. We included a study if: 1) it used stress
RI as a diagnostic test for obstructive CAD, with 50%
iameter stenosis selected as the threshold for significant
AD, using catheter-based X-ray angiography as the ref-
rence standard; and 2) reported cases in absolute numbers
f true positive, false positive, true negative, and false
egative results or stated data adequate to derive this
nformation. Studies were eligible regardless of whether
hey were referred for suspected or known CAD and
egardless of technique used for stress MRI. Studies were
xcluded if: 1) performed in phantom-only models; 2)
nimals; 3) normal healthy volunteers without catheter-
ased X-ray angiography correlation; or 4) included 10
atients.
ata extraction and quality assessment. Two indepen-
ent investigators performed data extraction. Inconsisten-
ies were resolved by discussion and consensus. Data were
ecorded, as available, at the coronary territory level (left
nterior descending, left circumflex, and right coronary
rteries) and patient level. Study quality and applicability
ere assessed by a modified checklist based on the Quality
ssessment Tool for Diagnostic Accuracy guidelines by 2
ndependent investigators, with discrepancies solved by
onsensus (1).
ata synthesis and statistical analysis. Categorical vari-
bles from studies are presented as percentages and contin-
ous variables as mean values. The main analysis was
erformed at the patient level, as most studies provided this
evel of information. Secondary analyses were performed at
he coronary territory level. We applied the bivariate mixed-
ffects regression model for treatment trial meta-analysis
nd modified for synthesis of diagnostic test data assuming
inomial errors distribution for sensitivity and specificity
Abbreviations
and Acronyms
CAD  coronary artery
disease
LR  likelihood ratio
MRI  magnetic resonance
imaging
SPECT  single-photon
emission tomography2,3). Between-study variability was assessed assuming cor-elated normally distributed random effects for logit (sensi-
ivity) and logit (specificity) with the degree of correlation
etween studies predictive of an implicit threshold effect.
e derived summary sensitivity and specificity as functions
f the estimated model parameters with associated 95% CIs.
stimate of clinical utility. The positive likelihood ratio
LR) measures the likelihood that a positive (abnormal)
tress MRI would be expected in a patient with CAD,
hereas the negative LR (LR) measures the likelihood
hat a negative (normal) stress MRI would be expected in a
atient without CAD. As a measure of test performance,
he LR has advantages over sensitivity and specificity as it
hanges with disease prevalence and can be used to calculate
ost-test probability. Positive likelihood ratio and LR are
efined with the following formulas: LR  sensitivity/
1  specificity) and LR  (1  sensitivity)/specificity.
We examined clinical utility of each method by means of
ayes’ theorem, where pretest probability  prevalence of
isease and post-test probability  LR  pretest probability/
(1  pretest probability)  (1  LR)]. Assuming that the
tudy samples are representative of the entire population, an
stimate of the pretest probability of CAD can be calculated
rom the global or subgroup-specific prevalence of this disorder
cross the studies. The weighted mean percentage of CAD of
he prevalence of CAD in patients who underwent stress MRI
as used as the pretest probability. The post-test probability
as evaluated by changing the pretest probability into pretest
dds with the following equation: odds  probability/(1 
robability). The post-test odds were then derived by multi-
lying together the pretest odds and the LR. Finally, the
ost-test odds were converted to probabilities by utilizing the
ollowing equation: probability  odds/(odds  1). These
Figure 1 Flow Diagram of Review Process
Process of identification and selection of studies for inclusion in meta-analysis.
Characteristics of Included Studies
Table 1 Characteristics of Included Studies
Author (Ref. #) Year Journal
Patients
(n) Excluded
Men
(%)
Mean
Age, yrs
(SD)
MRI
(Brand) and
Tesla
MRI
Technique MRI Sequence Data Assessment Stressor Selection
Stenosis
Definition
(%)
al-Saadi et al. (4) 2000 Circulation 40 6 80 59 (11) Philips 1.5-T Perfusion Inversion recovery
single-shot turbo
gradient-echo
Semiquantitative Dipyridamole Suspected CAD 75
al-Saadi et al. (5) 2002 Journal of
Cardiovascular
Magnetic
Resonance
23 0 70 59 (8) Philips 1.5-T Perfusion Inversion recovery
single-shot turbo
gradient-echo
Semiquantitative Dobutamine 23 patients with
CAD and 4
without CAD
75
Bunce et al. (6) 2004 Journal of
Cardiovascular
Magnetic
Resonance
35 0 77 56 (NS) Picker 1.5-T Perfusion Ultrafast gradient-
echo
Semiquantitative Adenosine Suspected CAD 50
Chiu et al. (7) 2003 Radiology 13 0 54 68 (NS) Siemens
1.5-T
Perfusion T1-weighted
inversion-
recovery true-
FISP
Qualitative Adenosine Suspected CAD 50
Cury et al. (8) 2006 Radiology 47 1 81 63 (5) GE 1.5-T Perfusion Hybrid gradient-
echo-planar
Qualitative Dipyridamole Suspected of
having or
known to have
CAD
70
Doyle et al. (9) 2003 Journal of
Cardiovascular
Magnetic
Resonance
199 15 0 59 (11) Philips 1.5-T Perfusion Gradient-echo Semiquantitative Dipyridamole Suspected CAD 70
Giang et al. (10) 2004 European
Heart Journal
44 0 81 58 (NS) GE 1.5-T Perfusion Hybrid echo-planar Semiquantitative Adenosine Suspected CAD 50
Ibrahim et al. (11) 2002 Journal of the
American
College of
Cardiology
25 NS 76 63 (13) Philips 1.5-T Perfusion Ultra-fast hybrid Semiquantitative Adenosine 25 with
documented
CAD
75
Ishida et al. (12) 2003 Radiology 104 0 78 66 (12) GE 1.5-T Perfusion Gradient-echo
sequence by
using fast echo-
planar readouts
and interleaved
notched
saturation
Qualitative Dipyridamole/
isometric
handgrip
exercise
Suspected CAD 70
Kawase et al. (13) 2004 Osaka City
Medical
Journal
50 0 58 67 (12) Philips 1.5-T Perfusion Multislice turbo
field echo with
multishot echo-
planar imaging
Qualitative Nicorandil Suspected CAD 70
Klem et al. (14) 2006 Journal of the
American
College of
Cardiology
95 3 49 58 (12) Siemens
1.5-T
Perfusion Hybrid of fast
gradient-echo
and echo-planar
Qualitative Adenosine Suspected CAD 70
Continued on next page
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Table 1 Continued
Author (Ref. #) Year Journal
Patients
(n) Excluded
Men
(%)
Mean
Age, yrs
(SD)
MRI
(Brand) and
Tesla
MRI
Technique MRI Sequence Data Assessment Stressor Selection
Stenosis
Definition
(%)
Nagel et al. (15) 2003 Circulation 90 6 81 63 (8) Philips 1.5-T Perfusion Turbo-gradient-
echo/echo-
planar imaging-
hybrid
Semiquantitative Adenosine Suspected CAD 75
Okuda et al. (16) 2005 Radiation
Medicine
33 0 88 60 (NS) GE 1.5-T Perfusion Gradient-echo with
echo-planar
Qualitative Dipyridamole Suspected CAD 75
Panting et al. (17) 2001 Journal of
Magnetic
Resonance
Imaging
17 0 81 63 (9) Surrey 0.5-T Perfusion Spin echo/echo-
planar
Semiquantitative/
qualitative
Adenosine Abnormal
thallium SPECT
scans
50
Pilz et al. (18) 2006 Clinical Research
in Cardiology
176 5 64 62 (12) GE 1.5-T Perfusion Hybrid of fast
gradient-echo
and echo-planar
acquisition
imaging
Qualitative Adenosine Suspected CAD 70
Plein et al. (19) 2004 Journal of the
American
College of
Cardiology
71 3 79 57 (11) Philips 1.5-T Perfusion T1-weighted
saturation
recovery
segmented
k-space
gradient-echo
pulse sequence
combined with
sensitivity
encoding
Qualitative Adenosine Suspected CAD 70
Plein et al. (20) 2005 Radiology 92 10 74 58 (NS) Philips 1.5-T Perfusion Saturation-recovery
segmented
k-space
gradient-echo
Semiquantitative Adenosine Suspected CAD 70
Rieber et al. (21) 2006 European
Heart Journal
43 0 88 65 (8) Siemens
1.5-T
Perfusion T1-weighted
saturation
recovery turbo
flash
Semiquantitative Adenosine Suspected CAD 50/FFR
Sakuma et al. (22) 2005 American
Journal of
Roentgenology
40 0 70 65 (9) Siemens
1.5-T
Perfusion Saturation-recovery
turbo fast low-
angle shot
Qualitative Dipyridamole Suspected CAD 70
Schwitter et al. (23) 2001 Circulation 48 1 85 58 (NS) GE 1.5-T Perfusion Hybrid echo-planar Semiquantitative Dipyridamole Suspected CAD 50
Sensky et al. (24) 2002 International
Journal of
Cardiovascular
Imaging
30 0 90 62 (NS) Siemens
1.5-T
Perfusion Dynamic inversion
recovery
snapshot
Qualitative Adenosine Known CAD 50
Takase et al. (25) 2004 Japan
Heart Journal
102 0 83 66 (9) GE 1.5-T Perfusion Hybrid of fast
gradient-echo
and echo-planar
Qualitative Dipyridamole Suspected CAD 50
Continued on next page
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Table 1 Continued
Author (Ref. #) Year Journal
Patients
(n) Excluded
Men
(%)
Mean
Age, yrs
(SD)
MRI
(Brand) and
Tesla
MRI
Technique MRI Sequence Data Assessment Stressor Selection
Stenosis
Definition
(%)
Thiele et al. (26) 2004 International
Journal of
Cardiovascular
Imaging
20 0 65 64 (8) Philips 1.5-T Perfusion Turbo gradient-
echo with
sensitivity
encoding
Semiquantitative Adenosine Suspected CAD 70
Baer et al. (27) 1992 American Journal
of Cardiology
23 0 96 60 (8) Philips 1.5-T Wall
motion
Gradient-echo Qualitative Dipyridamole Known CAD 70
Baer et al. (28) 1994 Radiology 35 3 80 58 (10) Philips 1.5-T Wall
motion
Gradient-echo Qualitative Dobutamine 35 patients with
CAD
50
Hundley et al. (29) 1999 Circulation 41 NS 56 NS GE 1.5-T Wall
motion
Gradient-echo
sequence with
k-space
segmentation
Semiquantitative Dobutamine
and
atropine
Poor acoustic
windows on TTE
50
Jahnke et al. (30) 2006 Radiology 40 0 75 63 (9) Philips 1.5-T Wall
motion
4-dimensional
k-t BLAST
Qualitative Dobutamine Suspected or
known CAD
50
Nagel et al. (31) 1999 Circulation 172 NS 71 60 (9) Philips 1.5-T Wall
motion
Gradient-echo Qualitative Dobutamine Suspected CAD 50
Paetsch et al. (32) 2004 Circulation 79 0 66 61 (9) Philips 1.5-T Wall
motion
Steady-state free
precession
Qualitative Dobutamine
and
atropine
Suspected or
known CAD
50
Paetsch et al. (32) 2004 Circulation 79 0 66 61 (9) Philips 1.5-T Perfusion Turbo field echo Qualitative Adenosine Suspected or
known CAD
Paetsch et al. (33) 2006 European
Heart Journal
150 0 83 61 (10) Philips 1.5-T Wall
motion
Steady-state free
precession
Qualitative Dobutamine Suspected CAD 50
Pennell et al. (34) 1990 British
Heart Journal
40 0 88 54 (NS) Picker 0.5-T Wall
motion
Field echo even
rephasing
Qualitative Dipyridamole Suspected CAD NS
Pennell et al. (35) 1992 American Journal
of Cardiology
25 0 74 52 (NS) Picker 0.5-T Wall
motion
Gradient-refocused,
velocity-
compensated
echo
Qualitative Dobutamine Suspected CAD 50
Rerkpattanapipat
et al. (36)
2003 American Journal
of Cardiology
27 0 86 62 (11) GE 1.5-T Wall
motion
Gradient- echo Qualitative Exercise Suspected CAD 70
Schalla et al. (37) 2002 Radiology 22 0 80 60 (5) Philips 1.5-T Wall
motion
Segmented k-
space turbo
gradient-echo
echo-planar
Qualitative Dobutamine Suspected CAD 75
van Rugge et al. (38) 1993 Journal of the
American
College of
Cardiology
45 0 82 61 (9) Philips 1.5-T Wall
motion
Gradient-echo Qualitative Dobutamine Suspected CAD 50
van Rugge et al. (39) 1994 Circulation 39 0 86 60 (NS) Philips 1.5-T Wall
motion
Gradient-echo Quantitative Dobutamine Suspected CAD 50
Zhao et al. (40) 1997 Magnetic
Resonance
Imaging
16 2 72 60 (7) Siemens
1.5-T
Wall
motion
Gradient-echo-
segmented
k-space
Qualitative and
quantitative
Dipyridamole Known CAD 70
CAD coronary artery disease; echo echocardiography; FFR fractional flow reserve; FISP fast imaging with steady-stage precession; MRImagnetic resonance imaging; NS not specified; SPECT single-photon emission computed tomography; TTE transthoracic
echocardiography.
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Table 2 Per Patient, Per Coronary Territory Analysis
Analysis by Patient Analysis by Coronary Territory
Author (Ref. #) n TP (n) FN (n) FP (n) TN (n) Sensitivity Specificity n TP (n) FN (n) FP (n) TN (n) Sensitivity Specificity
MRI perfusion
al-Saadi et al. (4) 102 54 6 7 35 0.90 0.83
al-Saadi et al. (5) 69 26 6 10 27 0.81 0.73
Bunce et al. (6) 105 26 9 20 50 0.74 0.71
Chiu et al. (7) 39 24 2 1 12 0.92 0.92
Cury et al. (8) 46 29 1 4 12 0.97 0.75 138 47 7 9 75 0.87 0.89
Doyle et al. (9) 184 15 11 35 123 0.57 0.78
Giang et al. (10) 44 26 2 4 12 0.93 0.75
Ibrahim et al. (11) 75 10 4 7 54 0.71 0.89
Ishida et al. (12) 104 69 8 4 23 0.90 0.85 312 109 21 32 150 0.84 0.82
Kawase et al. (13) 50 31 2 1 16 0.94 0.94 150 34 5 14 97 0.87 0.87
Klem et al. (14) 92 33 4 7 48 0.89 0.87 264 45 11 22 186 0.80 0.89
Nagel et al. (15) 84 38 5 4 37 0.88 0.90
Okuda et al. (16) 94 42 7 5 40 0.89 0.85
Panting et al. (17) 51 27 8 3 13 0.77 0.81
Pilz et al. (18) 171 109 4 10 48 0.96 0.83
Plein et al. (19) 68 54 2 2 10 0.96 0.83 204 72 17 27 88 0.81 0.77
Plein et al. (20) 82 52 7 6 17 0.88 0.74
Rieber et al. (21) 42 11 2 3 26 0.85 0.90
Sakuma et al. (22) 40 17 4 6 13 0.81 0.68 120 23 10 11 76 0.70 0.87
Schwitter et al. (23) 47 32 5 3 7 0.86 0.70
Sensky et al. (24) 86 66 5 6 9 0.93 0.60
Takase et al. (25) 102 71 5 4 22 0.93 0.85
Thiele et al. (26) 60 21 7 1 31 0.75 0.97
MRI wall motion
Baer et al. (27) 23 18 5 0 0 0.78 69 26 7 3 33 0.79 0.92
Baer et al. (28)* 32 27 5 0 0 0.84 64 36 11 0 17 0.77 1.00
Hundley et al. (29) 41 29 6 1 5 0.83 0.83
Jahnke et al. (30) 40 25 3 3 9 0.89 0.75 120 23 5 13 79 0.82 0.86
Nagel et al. (31) 172 94 15 9 54 0.86 0.86
Paetsch et al. (PI) (32) 79 48 5 10 16 0.91 0.62
Paetsch et al. (WMA) (32) 79 47 6 5 21 0.89 0.81
Paetsch et al. (33) 150 60 17 9 64 0.78 0.88
Pennell et al. (34) 40 24 15 0 1 0.62 1.00
Pennell et al. (35) 25 20 2 0 3 0.91 1.00
Rerkpattanapipat et al. (36) 27 11 3 2 11 0.79 0.85
Schalla et al. (37) 22 13 3 1 5 0.81 0.83
van Rugge et al. (38) 45 30 7 0 8 0.81 1.00
van Rugge et al. (39) 39 30 3 1 5 0.91 0.83
Zhao et al. (40) 36 16 4 4 12 0.80 0.75
*Utilized 2 perfusion territories (left anterior descending coronary artery and combined left circumflex artery/right coronary artery).
FN  false negative; FP  false positive; MRI  magnetic resonance imaging; PI  perfusion imaging; TN  true negative; TP  true positive; WMA  wall motion abnormalities.
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October 2, 2007:1343–53 Meta-Analysis of Stress Cardiac MRIesults are represented in a graph of conditional probabilities
isplaying the post-test probability of CAD, if the test was
egative or positive, for a given pretest probability.
ssessment of heterogeneity. Heterogeneity of the results
etween the studies was assessed graphically by forest plots
nd statistically using the quantity I2 that describes the
ercentage of total variation across studies attributable to
eterogeneity rather than chance.
Statistical analyses were performed with Stata 9.0 (Stata
orp., Chicago, Illinois).
esults
he literature process is summarized in Figure 1. Database
earches identified 48 potentially relevant citations. Thirty-
even studies were included, with 11 being excluded be-
ause: 1) they had overlapping data; or 2) it was not possible
o calculate absolute figures from the presented data. Study
nd population characteristics of the included studies are
ummarized in Table 1 (4–40).
Data on diagnostic accuracy were available for the 37
tudies with a total of 2,191 patients, with 14 comparisons
754 patients) using stress-induced wall motion abnormal-
ties imaging and 24 comparisons (1,516 patients) using
Figure 2 Forest Plot of Sensitivity and Specificity
(A, B) Forest plot of patient-level sensitivity and specificity of stress perfusion ima
and specificity of stress-induced wall motion abnormalities imaging compared with
relative contribution of the study to meta-analysis); horizontal lines  95% confideerfusion imaging. One study directly compared stress- snduced wall motion abnormalities imaging and perfusion
maging in the same patients (79 patients) (32). Results of
he individual studies on a per-patient and per-coronary
erritory level are summarized in Table 2.
atient-level summary performance estimates. After
ooling 14 datasets (1,183 patients after exclusion of 50
atients secondary to unsuccessful MRI), perfusion imaging
emonstrated a sensitivity of 0.91 (95% CI 0.88 to 0.94) and
pecificity of 0.81 (95% CI 0.77 to 0.85), compared with
atheter-based X-ray angiography (Fig. 2A). The preva-
ence of CAD in this group was 57.4% (679 of 1,183). After
ooling 13 datasets (735 patients after exclusion of 5
atients secondary to unsuccessful MRI), stress-induced
all motion abnormalities imaging demonstrated a sensi-
ivity of 0.83 (95% CI 0.79 to 0.88) and specificity of 0.86
95% CI 0.81 to 0.91) for CAD at the subject level (Fig.
B). The prevalence of CAD in this group was 70.5% (518
f 735). Overall, these summary estimates show good
ensitivity and specificity for CAD at the patient level.
nalysis of stress-induced wall motion abnormalities imag-
ng with dobutamine or exercise as the stressor (excluding
tudies utilizing dipyridamole) demonstrates an improved
ensitivity of 0.85 (95% CI 0.82 to 0.90) with a comparable
ompared with coronary angiography. (C, D) Forest plot of patient level sensitivity
ary angiography. Solid squares  point estimate of each study (area indicates
terval (CI).ging c
coron
nce inpecificity of 0.86 (95% CI 0.81 to 0.91).
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Meta-Analysis of Stress Cardiac MRI October 2, 2007:1343–53Evaluating clinical utility, the positive LR for perfusion
RI is 5.10 (95% CI 3.92 to 6.28); the negative LR, 0.11
95% CI 0.07 to 0.15). For stress-induced wall motion
bnormalities imaging, the positive LR is 5.24 (95% CI 3.28
o 7.21); the negative LR, 0.19 (95% CI 0.15 to 0.24).
sing the rule of thumb that for a diagnostic test to be
seful it should have a high positive LR (5) (i.e., good at
uling in a disease) and a low negative LR (0.2) (i.e., good
t ruling out disease), both methods are good at confirming
nd excluding CAD. For each test, Figure 3 shows the effect
f a positive or negative result on pretest probabilities.
oronary territory-level summary performance estimates.
er-coronary territory meta-analysis of perfusion imaging
ooled 16 datasets with 1,911 coronary territories and demon-
trated a sensitivity of 0.84 (95% CI 0.80 to 0.87) and
pecificity of 0.85 (95% CI 0.81 to 0.88). Per-coronary territory
eta-analysis of stress-induced wall motion abnormalities
maging pooled 4 datasets with 289 coronary territories and
emonstrated a sensitivity of 0.79 (95% CI 0.71 to 0.86) and
pecificity of 0.93 (95% CI 0.81 to 1.0), although notably
imited by a small study size.
ssessment of heterogeneity. Analysis at the patient level
emonstrated moderate heterogeneity in sensitivities between
erfusion imaging studies (I2  0.44, p  0.04) and specific-
ties between stress-induced wall motion abnormality studies
I2  0.73, p  0.001). At the coronary territory level,
eterogeneity was present for between-study specificities for
oth perfusion (I2  0.62, p 0.001) and stress-induced wall
otion abnormality studies (I2  0.85, p  0.001).
Figure 3 Plot of Conditional Probabilities for PI and IWMA
Post-test probabilities are shown as a function of pretest probability for
patients with positive results on perfusion imaging (PI), positive results on wall
motion abnormalities imaging (IWMA), negative results on PI, and negative
results on IWMA.Quality grading by study is shown in Table 3. fiscussion
tress MRI has recently emerged as a promising alternative
o nuclear SPECT and stress echocardiography in the
oninvasive functional evaluation of CAD. Our study ex-
mined the diagnostic performance data of stress MRI from
ultiple centers throughout the world describing popula-
ions with a relatively high prevalence of disease, 57% in the
erfusion imaging group and 71% in the stress-induced wall
otion abnormalities imaging group. At the patient level,
e found that the 2 main techniques, perfusion imaging and
tress-induced wall motion abnormalities imaging, used in
tress MRI demonstrated similar good specificities (perfu-
ion imaging: 81%, stress-induced wall motion abnormali-
ies imaging: 86%) and sensitivities (perfusion imaging:
1%, stress-induced wall motion abnormalities imaging:
3%). With the exclusion of stress-induced wall motion
bnormalities studies utilizing dipyridamole, which may be
less effective stressor for this technique, and inclusion of
hose with dobutamine or exercise, the sensitivity of wall
otion imaging was improved (85%) without a notable
hange in the specificity (40). At the coronary territory level,
erfusion imaging and stress-induced wall motion abnor-
alities imaging showed overlapping sensitivities and spec-
ficities that were good overall.
The wide range of prevalence of CAD in the examined
tudies likely reflects institutional referral patterns and
linical thresholds for imaging patients. As post-test
robability depends on disease prevalence, practical use of
he results relies on cognizance of CAD prevalence at any
ndividual medical center. In our study, the summary
ensitivities and specificities for perfusion imaging and
tress-induced wall motion abnormalities imaging were
ttained in patients selected to undergo an invasive
xamination, catheter-based X-ray angiography, and thus
ad relatively high probability of CAD. This selection
ias is illustrated by the high prevalence of disease in both
echnique populations. Limited empiric data are available
n low disease prevalence populations, except in a few
tudies (9,14). Moreover, similar studies in a low-risk
opulation would be difficult to conduct given the strong
rognostic value of a negative stress MRI (41).
The diagnostic capabilities of stress MRI, especially with
erfusion imaging, appear comparable if not superior to
PECT and stress echocardiography. Underwood et al. (42)
xamined 79 studies with 8,964 patients using SPECT in
he diagnosis of CAD and found a sensitivity of 86% and
pecificity of 74%, with the caveat that the low specificity
ay be partially due to referral bias. Ishida et al. (12) directly
ompared perfusion imaging and SPECT in 69 patients
ho also underwent catheter-based X-ray angiography and
ound a significantly greater area under the receiver-
perating characteristic curve for perfusion imaging com-
ared with that in SPECT, and Sakuma et al. (22) found
uperior but not statistically significant diagnostic accuracy
or perfusion imaging compared with that in SPECT in 40
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October 2, 2007:1343–53 Meta-Analysis of Stress Cardiac MRIatients. The favorable capabilities of stress MRI, specifi-
ally perfusion imaging, are likely due to superior spatial
esolution compared with that in SPECT allowing for the
istinction between subendocardial and transmural defects,
hich is important because subendocardial perfusion defects
an indicate ischemia at an early stage. Single-photon
mission computed tomography also has the disadvantages
f radiation exposure and attenuation artifacts. Although,
otably, stress MRI, with perfusion imaging or stress-
nduced wall motion abnormalities imaging, can be limited
y availability, claustrophobia, obesity, poor gating, and
otion artifact, along with the use of pharmacologic stres-
ors, and attaining the appropriate heart rate (for stress-
uality Assessment
Table 3 Quality Assessment
Author (Ref. #) Item 1 Item 2 Item 3 Item 4
al-Saadi et al. (4) Yes Yes Yes Yes
al-Saadi et al. (5) Yes No Yes NS
Bunce et al. (6) Yes Yes Yes Yes
Chiu et al. (7) Yes Yes Yes No
Cury et al. (8) Yes No Yes Yes
Doyle et al. (9) Yes Yes No Yes
Giang et al. (10) Yes Yes Yes NS
Ibrahim et al. (11) Yes No No No
Ishida et al. (12) Yes Yes Yes NS
Kawase et al. (13) Yes Yes Yes Yes
Klem et al. (14) Yes Yes Yes Yes
Nagel et al. (15) Yes Yes No Yes
Okuda et al. (16) Yes Yes Yes NS
Panting et al. (17) Yes No No No
Pilz et al. (18) Yes Yes Yes Yes
Plein et al. (19) Yes Yes Yes Yes
Plein et al. (20) Yes No Yes NS
Rieber et al. (21) Yes Yes No Yes
Sakuma et al. (22) Yes Yes Yes No
Schwitter et al. (23) Yes No No No
Sensky et al. (24) Yes No Yes NS
Takase et al. (25) Yes Yes Yes Yes
Thiele et al. (26) Yes Yes No NS
Baer et al. (27) Yes No Yes Yes
Baer et al. (28) Yes No Yes Yes
Hundley et al. (29) Yes Yes Yes NS
Jahnke et al. (30) Yes No Yes No
Nagel et al. (31) Yes Yes Yes NS
Paetsch et al. (32) Yes Yes Yes Yes
Paetsch et al. (33) Yes Yes Yes Yes
Pennell et al. (34) Yes Yes Yes NS
Pennell et al. (35) Yes Yes Yes NS
Rerkpattanapipat et al. (36) Yes Yes Yes NS
Schalla et al. (37) Yes Yes Yes Yes
van Rugge et al. (38) Yes Yes Yes Yes
van Rugge et al. (39) Yes Yes No NS
Zhao et al. (40) Yes No Yes Yes
tem 1: Was the population clinically relevant, defined as a group of patients covering the spectru
omplete verification by the reference standard? Item 3: Was there blinded interpretation of the t
f patients? Item 6: Was there adequate description and quality of the imaging procedure? Item 7: W
f the patient population? Item 9: Was the sample size 35 patients? Item 10: Was there adequ
NS  not specified.nduced wall motion abnormalities imaging). With regard mo stress exercise echocardiography, Schuijf et al. (43)
ooled 15 studies with 1,849 patients and found a weighted
ean sensitivity and specificity of 84% and 82% for the
etection of CAD, and a weighted mean sensitivity and
pecificity of 80% and 84% in 28 studies with 2,246 patients
sing dobutamine echocardiography. Nagel el al. (31) found
tress-induced wall motion abnormalities imaging to have
ignificantly higher sensitivity and specificity than dobut-
mine stress echocardiography in a study with over 170
atients.
The American College of Cardiology recently reported
hat stress cardiac MRI, with either technique, is indicated
or detection of CAD in symptomatic patients with inter-
5 Item 6 Item 7 Item 8 Item 9 Item 10 Score
s Yes Yes Yes Yes No 9
s Yes Yes Yes No No 6
s Yes Yes Yes Yes Yes 10
o Yes Yes Yes No No 6
s Yes Yes Yes Yes Yes 9
s Yes Yes Yes Yes No 8
s Yes Yes Yes Yes Yes 9
s Yes Yes Yes No No 5
s Yes Yes Yes Yes Yes 9
s Yes Yes No Yes No 8
s Yes Yes Yes Yes No 9
s Yes Yes No Yes No 7
s Yes Yes No No No 6
S Yes Yes No No No 3
s Yes Yes Yes Yes No 9
s Yes Yes Yes Yes Yes 10
s Yes Yes Yes Yes No 7
s Yes Yes Yes Yes Yes 9
o Yes Yes No Yes No 6
s Yes Yes Yes Yes Yes 7
S Yes Yes No No Yes 5
s Yes Yes Yes Yes No 9
s Yes Yes Yes No Yes 7
s Yes Yes No Yes No 7
s Yes Yes No Yes Yes 8
s Yes Yes Yes Yes No 8
s Yes Yes Yes Yes Yes 8
s Yes Yes No Yes No 7
s Yes Yes Yes Yes Yes 10
s Yes Yes Yes Yes Yes 10
s Yes Yes No Yes No 7
s Yes Yes No No No 6
s Yes Yes Yes No No 7
s Yes Yes Yes No No 8
s Yes Yes No Yes Yes 9
s Yes Yes No Yes Yes 7
s Yes Yes No No Yes 7
isease that is likely to be encountered in the current or future use of the test? Item 2: Was there
ults? Item 4: Was there consecutive patient selection? Item 5: Was there prospective enrollment
quality of the reference test technically adequate? Item 8: Was there adequate clinical description
orting of results, including summary and subgroup indexes of accuracy?Item
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tated that stress cardiac MRI is of uncertain usefulness in
ymptomatic patients with a high pretest probability of
AD. From our analysis, the clinical utility of stress cardiac
maging, using either technique, is most evident when the
est is negative, decreasing the probability of CAD to at or
elow 20% in patients with low-to-intermediate pretest
robability of CAD (60%). A positive test appears more
seful with intermediate-to-high pretest probabilities
40%), where the post-test probability of disease would
xceed approximately 80%. Consequently, our analysis sup-
orts the use of stress cardiac MRI in patients with
ntermediate pretest probability disease, as both a positive
nd negative test confer a relatively acceptable post-test
robability of disease, while its role in high pretest proba-
ility of disease needs to be further evaluated, given the
tility of a positive test but questionable usefulness if
egative.
Our study contains several limitations. Significant het-
rogeneity was identified in multiple performance charac-
eristics; thus the results and potential clinical application
hould be interpreted with caution. Not all of the included
tudies provided comprehensive data on the patient and
oronary territory level, although numerous investigators
ere contacted to provide additional data. Moreover, lim-
ted or ambiguous information was provided by many
tudies regarding the number of examinations that were not
nterpretable, which can lead to false estimates of sensitivity
nd specificity. Future studies should be promoted to have
ore rigorous reporting of results. Publication bias, favoring
tudies with positive results, also confounds comprehensive
valuation. Quality assessment and data abstraction were
erformed by independent reviewers, with disagreement
ettled by consensus. Consequently, quantitative agreement
etween the reviewers could not be examined. An anatomy-
ased gold standard, catheter-based angiography was uti-
ized, which is imperfect, particularly with regard to phys-
ological information. Stress MRI technology has been
volving since the earliest studies and newer additional
echniques, such as the addition of coronary magnetic
esonance angiography, double contrast bolus technique,
nd delayed enhancement infarction imaging, which were
tilized in only a small number of studies in the current
eta-analysis, may further improve the diagnostic proper-
ies of stress MRI.
onclusions
tress perfusion MRI, with either perfusion imaging or
all-motion imaging, has good sensitivity and specificity in
he diagnosis of CAD, in patients with a high prevalence of
isease. However, we recommend cautious clinical applica-
ion of the results, given the limited data available for a low
isease prevalence population.cknowledgments
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